|
Name |
6-epi-Ophiobolin K
|
Molecular Formula | C25H36O3 | |
IUPAC Name* |
(1R,3S,4R,7R,8E,11S,12R)-4-hydroxy-1,4-dimethyl-12-[(2S,3Z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.03,7]tetradec-8-ene-8-carbaldehyde
|
|
SMILES |
C[C@@H](/C=C\C=C(C)C)[C@H]1CC[C@]2([C@H]1C/C=C(\[C@H]3[C@H](C2)[C@](CC3=O)(C)O)/C=O)C
|
|
InChI |
InChI=1S/C25H36O3/c1-16(2)7-6-8-17(3)19-11-12-24(4)13-21-23(22(27)14-25(21,5)28)18(15-26)9-10-20(19)24/h6-9,15,17,19-21,23,28H,10-14H2,1-5H3/b8-6-,18-9-/t17-,19+,20-,21-,23-,24+,25+/m0/s1
|
|
InChIKey |
TXEVVAPERSDMTN-NIBMOTIQSA-N
|
|
Synonyms |
6-epi-Ophiobolin K; CHEMBL4163776; BDBM50523068; BS-1410
|
|
CAS | NA | |
PubChem CID | 10317884 | |
ChEMBL ID | CHEMBL4163776 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.6 | ALogp: | 4.9 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 54.4 | Aromatic Rings: | 3 |
Heavy Atoms: | 28 | QED Weighted: | 0.523 |
Caco-2 Permeability: | -4.659 | MDCK Permeability: | 0.00002070 |
Pgp-inhibitor: | 0.98 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.112 | 20% Bioavailability (F20%): | 0.931 |
30% Bioavailability (F30%): | 0.774 |
Blood-Brain-Barrier Penetration (BBB): | 0.056 | Plasma Protein Binding (PPB): | 95.39% |
Volume Distribution (VD): | 1.357 | Fu: | 2.58% |
CYP1A2-inhibitor: | 0.6 | CYP1A2-substrate: | 0.601 |
CYP2C19-inhibitor: | 0.769 | CYP2C19-substrate: | 0.869 |
CYP2C9-inhibitor: | 0.825 | CYP2C9-substrate: | 0.068 |
CYP2D6-inhibitor: | 0.751 | CYP2D6-substrate: | 0.057 |
CYP3A4-inhibitor: | 0.914 | CYP3A4-substrate: | 0.79 |
Clearance (CL): | 2.852 | Half-life (T1/2): | 0.193 |
hERG Blockers: | 0.389 | Human Hepatotoxicity (H-HT): | 0.277 |
Drug-inuced Liver Injury (DILI): | 0.436 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0.042 | Maximum Recommended Daily Dose: | 0.966 |
Skin Sensitization: | 0.954 | Carcinogencity: | 0.147 |
Eye Corrosion: | 0.228 | Eye Irritation: | 0.246 |
Respiratory Toxicity: | 0.973 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003783 | 1.000 | D0I2SD | 0.274 | ||||
ENC003687 | 0.691 | D0P0HT | 0.265 | ||||
ENC003251 | 0.685 | D04SFH | 0.263 | ||||
ENC002983 | 0.632 | D04GJN | 0.263 | ||||
ENC005803 | 0.563 | D06AEO | 0.256 | ||||
ENC001559 | 0.535 | D0K0EK | 0.250 | ||||
ENC002981 | 0.495 | D07BSQ | 0.250 | ||||
ENC003777 | 0.481 | D0F1UL | 0.250 | ||||
ENC002982 | 0.430 | D0B4RU | 0.250 | ||||
ENC005047 | 0.409 | D0Q6NZ | 0.246 |